E2F1 and familial pancreatic carcinoma: Our results point at E2F1 as a regulatory factor modulating gemcitabine induced VMP1-mediated autophagy in human pancreatic cancer cells and mechanistically integrate the autophagic degradative process into the complex network of events involved in PDAC chemoresistance.